• Physiological doses of E2 show neuroprotective effects in adult female mice but not in aged female mice.
Introduction
Ischemic stroke is one of the leading causes of death worldwide [1] . Among the elderly, women are more likely than men to suffer from stroke [2] , and the neurological outcomes for female patients are also worse compared with those for men [3] . Furthermore, compared with younger premenopausal women, older postmenopausal women are more likely to have stroke.
Numerous studies have shown that 17␤-estradiol (E2) therapies are beneficial for ischemic stroke [4] . However, there has been significant controversy concerning the neuroprotective effects of E2. Two clinical studies from the Women's Estrogen for Stroke Trial and the Women's Health Initiative found that E2 therapy failed to achieve protective effects and perhaps even increased the risk for dementia and stroke [5, 6] . Other clinical trials have demonstrated that postmenopausal women who received E2 treatment were more likely to suffer from stroke [7] and had more severe outcomes than postmenopausal women who did not receive the therapy [8] . Furthermore, experimental studies in a long-term E2 deprivation (LTED) model revealed that the neurodegenerative effects of E2 are caused by multiple factors including decreased E2 sensitivity and decreased expression of ER␣ following ischemia [9] .
In this study, we utilized 22-month-old female mice and a MCAO model to explore the effects of estrogen on ischemic injury in postmenopausal females. We also explored the mechanisms underlying the loss of estrogen efficacy against ischemic injury in aged females by examining the expression of estrogen receptors (ER) ␣ and ␤ in the cerebral cortex.
Materials and methods

Mice
Eighty 3-month-old (20-25 g) and 120 22-month-old (25-30 g) female C57BL/6 mice were obtained from the Experimental Animal Center of the Fourth Military Medical University. The mice were divided into a total of seven groups. The 80 adult mice were randomly divided into four groups (n = 20): (A) sham control; (B) OVX without E2; (C) OVX + low E2; and (D) OVX + high E2. The 120 aged mice were randomly divided into three groups (n = 40): (E) sham control; (F) aged + low E2; and (G) aged + high E2. In each group, five mice were used to detect the level of serum estrogen and the expression of ER␣ and ER␤, while others (15 or 35 mice) received MCAO treatment. The experiment protocol was approved by the Ethics Committee for Animal Experimentation of the Fourth Military Medical University.
OVX and estrogen replacement
OVX was performed by dorsolateral incision, as previously described [10] . Briefly, after the animals were anesthetized, bilateral OVX surgery was carried out through two small lateral abdominal incisions, and both the right and left horns of the uterus were exposed. The ovaries were then carefully removed, leaving the uterus intact. Animals in the sham groups were subjected to the same operation, with the exception that the ovaries were left intact. Five days following OVX, the animals began receiving daily subcutaneous injections of 100 g/kg or 300 g/kg E2 (diluted in sesame oil solution) at the back of the neck for next four weeks.
Determination of serum estrogen levels
The levels of serum estrogen were measured to confirm HRT. Briefly, the animals were anesthetized with an overdose of pentobarbital sodium, and blood was collected from the ophthalmic artery. Serum estradiol levels were measured using an EIA kit (Cayman Chemical, Ann Arbor, MI).
Real-time PCR
To analyze the expression of the ER␣ and ER␤ mRNAs in the cerebral cortex, real-time PCR was performed as previously described [11] . Briefly, total RNA was extracted from individual samples of cerebral cortex using TRIzol (Invitrogen, America) and reverse transcribed into cDNA using the RevertAidTM First-Strand cDNA synthesis kit (Fermentas, Lithuania). The mRNA transcript levels were determined by quantitative real-time PCR using cDNA as the template, appropriate specific primers and the SYBR Green RT-PCR kit (Takara, Japan). The following primer pairs (Takara, Japan) were used: ER␣ sense (5 -TCTGGGTATCATTACGGTGTCTGG-3 ) and antisense (5 -GGTACACTGATTCGTGGCTGGA-3 ); ER␤ sense (5 -TCTGGGTATCATTACGGTGTCTGG-3 ) and antisense (5 -GGTACACTGATT CGTGGCTGGA-3 ); and GAPDH sense (5 -TCCTGTGGCATCCACGAAACT-3 ) and antisense (5 -GGAGGGAGCAATGATCTTGATCTTC-3 ). The expression levels of the target-gene mRNA transcripts were normalized relative to GAPDH controls.
Western blotting analyses
The expression of ER␣ and ER␤ in the cortex was determined using Western blotting analysis as described previously [12] . Briefly, the cortex were rapidly harvested and were homogenized on ice in RIPA lysis buffer containing 1 mM PMSF. Equal amounts of protein (30 g) were loaded into each lane of a 10% SDS-PAGE gel, subjected to electrophoresis and transferred onto a polyvinylidene fluoride (PVDF) membrane. The membranes were blocked in 5% BSA for 1 h and were then incubated with 1:1000 dilutions of mouse anti-ER␣ (Abcam, USA), anti-ER␤ (Abcam) or anti-␤ actin (Abcam) antibodies overnight at 4 • C. The membranes were then incubated with a HRP-conjugated secondary antibody for 2 h. Finally, the bands were visualized using Super Signal West PicoChemiluminescence Substrate.
MCAO
Four weeks after HRT, MCAO was conducted as previously described [12] . Cerebral blood flow was monitored using laser Doppler flowmetry (PeriFlux 5000; Perimed AB, Järfälla, Sweden). During surgery, an occlusion was considered to be successful when blood flow declined to less than 15% of the pre-ischemic baseline level; otherwise, the animals were discarded. Following 1 h of transient occlusion, cerebral blood flow was restored by removing the nylon suture for 24 h. Physiological parameters, blood pressure and blood gas, were monitored.
Neurobehavioral evaluation
Neurological behaviors in the mice were assessed 24 h after reperfusion using the Longa Score Scale [13] : (0) no deficit; (1) failure to extend left forepaw fully; (2) circling to the left; (3) falling to the left; (4) no spontaneous walking and decreased consciousness; and (5) dead. The neurological scores are expressed as median values with interquartile ranges.
Infarct volume assessment
The infarct volume was assessed by TTC staining as previously described [14] . Briefly, the mice were decapitated following blood collection. The brain was rapidly removed and coronal sections (1 mm) were prepared, immersed in 2% TTC at 37 • C for 30 min and then fixed with 4% paraformaldehyde for 24 h. The brain slices were photographed using a digital camera (Canon, Japan). Unstained areas were defined as infarcts and quantified using Photoshop CS3. The infarct volume was calculated by multiplying unstained areas and the slice thickness. The total infarct volume was calculated by summing the areas from all six slices.
Statistical analyses
The SPSS 13.0 software program for Windows was used for all statistical analyses. With the exception of the neurobehavioral scores, all values are expressed as means ± standard deviation (SD) and were analyzed using a one-way analysis of variance (ANOVA). Differences between groups were tested using the Tukey post hoc test. Neurological scores are presented as median values with interquartile ranges and were analyzed using the non-parametric Kruskal-Wallis test followed by the Mann-Whitney U-test with Bonferroni correction. Values of P < 0.05 were considered to be statistically significant.
Results
3.
1. OVX mice without E2 replacement showed significant weight gain (Table 1) Among the adult groups, the OVX mice without E2 replacement therapy showed significantly increased body weight compared with controls. However, E2 replacement therapy reversed this effect; the difference between the lower and higher E2 groups was not significantly different.
E2 replacement therapy significantly increased serum estrogen levels
Serum estrogen levels were measured to confirm the efficacy of HRT. As shown in Fig. 1 , among the adult mice, the serum estrogen levels in the OVX group were decreased by 52.3% compared with the sham control group. The serum estrogen levels in the 100 g/kg and 300 g/kg E2 groups were 2.21-and 5.45-fold greater than in the OVX group, respectively. Among the aged mice, serum estrogen levels in the control group were 6.9 ± 2.7 pg/ml, which was similar to that in the adult OVX group, whereas estrogen levels in the 100 g/kg and 300 g/kg E2 groups were 3.82-and 8.71-fold higher.
E2 replacement therapy did not significantly increase ERą nd ERˇ mRNA levels in the cerebral cortex
The mRNA levels of ER␣ and ER␤ were evaluated using real-time PCR. As shown in Supplementary Fig. 1 , in both the adult and aged groups, no significant differences were observed among the groups treated with different doses of E2 and the control or OVX groups.
E2 replacement therapy caused increased expression of ERą nd ERˇ protein in the adult groups but not in the aged groups
Western blotting analysis was used to determine the expression of ER␣ and ER␤ protein levels in the cerebral cortex following HRT. As shown in Fig. 2 , among the adult groups, the expression of ER␣ and ER␤ in the OVX group was markedly decreased compared with the control group. However, following HRT, the levels of ER␣ and ER␤ protein were significantly increased in both the lower and higher E2 groups.
As shown in Fig. 2 , ER␣ and ER␤ protein levels were low in the aged control group and were similar to that observed in the adult OVX group. Furthermore, E2 replacement therapy did not significantly increase the expression of ER␣ or ER␤ in aged mice.
Physiological doses of E2 show neuroprotective effects in adult female mice but not in aged female mice
The physiological parameters of the animals during the MCAO period are summarized in Supplementary Table 1. Blood pressure and blood gas remained within the normal range and no significant differences in physiological parameters were observed among the groups.
The MCAO surgeries were performed with regional cerebral blood flow (rCBF) monitoring. As shown in Supplementary Fig. 2 , cerebral blood flow in the adult and aged mice declined to 15% of baseline during the 1 h period of transient occlusion, which is generally considered to be a successful MCAO model.
To evaluate the neuroprotective effects of physiological doses of E2 against ischemia-reperfusion injury following MCAO, we scored for a variety of neurological deficits and assessed infarct volume in the cortex. As shown in Fig. 3 , among the adult mice, the OVX group showed significantly higher neurological deficit scores compared with the control group. Treatment with 100 g/kg or 300 g/kg E2 significantly improved the neurological deficit scores compared with the OVX group, suggesting that both lower and higher E2 dosages can significantly mitigate the neurological deficits caused by OVX and MCAO; no significant difference was observed between the lower and higher E2 groups. In the aged female mice, the neurological deficit score of the aged control group was significantly higher compared with the adult control group and had no significant difference with the adult OVX group. Furthermore, physiological doses of E2 did not improve neurological deficit scores in aged female mice following ischemia-reperfusion injury induced by MCAO. Data are shown as the mean ± SD. In aged mice, body weight was not significantly different among the two treatment and single control groups. * P < 0.05 vs. the adult control group. # P < 0.05 vs. the adult OVX group. Fig. 3 . Neurological deficit scoring. Longa Score Scale was used to assess the neurological behaviors of the mice 24 h after reperfusion. Neurological scores are presented as median values with interquartile ranges; * P < 0.05, *** P < 0.0001 vs. the adult control group; # P < 0.05 vs. the adult OVX group.
As shown in Fig. 4 , among the adult mice, the ration of infarct volume to the volume of contralateral hemisphere was 18.6 ± 2.6% in the sham control group, and OVX caused a significant increase in the infarct volume to 45.8 ± 3.8%. Treatment with 100 g/kg or 300 g/kg E2 significantly decreased the infarct volume to 20.2 ± 2.9% and 23.1 ± 2.7%, respectively. Among the aged mice, the infarct volume of the aged control group increased into 67.5 ± 6.8%, which was significantly larger than that of the adult control group and of the adult OVX group. Furthermore, treatment with 100 g/kg or 300 g/kg E2 resulted in the infarct volume as 63.8 ± 5.3% and 68.3 ± 7.2%, which were similar to the aged control group.
Discussion
The aim of this study was to determine whether exogenous E2 replacement therapy can alleviate ischemia-reperfusion injury in aged postmenopausal animals. Two different doses of E2 were used to mimic lower and higher physiological levels of serum estrogen.
Our results showed that the adult female animals with OVX surgery exhibited severe ischemic injury; and both the lower and higher doses of E2 significantly alleviated the ischemic injury. These results confirmed the neuroprotective effects of E2 and also demonstrated that the short-term OVX may not alleviate the neuroprotective effects of E2. It is interesting to note that the mice in the aged control group even demonstrated more severe ischemic injury than the adult OVX mice, and this may be due to the other physiological changes in aged mice which lead to the decrease in the ability of ischemic tolerance. However, we found that E2 appeared not to exhibit neuroprotective effect on aged mice, which was consistent with a previous study [15] that E2 is unable to exert neuroprotection against global cerebral ischemia (GCI) injury in 24-month-old and LTED rats. Nevertheless, several studies have demonstrated that long-term treatment with 17␤-estradiol can lead to more severe ischemic injury in LTED models [9] . This discrepancy may be due to the different animals and experimental models used in these studies. LTED is an excellent model of surgical menopause and has also been used as a model of natural menopause. However, the model is generally performed in young animals, and thus may not completely recapitulate or predict changes that occur along natural aging. Moreover, the GCI model is usually used to explore the association between ERs and the morphology and physiology of hippocampal neurons. In contrast, we used the MCAO model to study ischemia-reperfusion injury, which primarily affects the striatum and cortex.
E2 usually binds to its nuclear receptors, ER␣ and ER␤, which are expressed widely in the brain [16] , exhibiting the physiological or pharmacological effects in the central nervous system (CNS). It has been suggested that ER␣ plays a critical role in E2 neuroprotection [17] and ER␤ was correlated with several neurodegenerative diseases [18] . In this study, we found that in cerebral cortex of adult OVX and aged mice, ER␣ and ER␤ mRNA levels did not change, but their protein levels significantly decreased and E2 treatment did not rescue ER␣ and ER␤ protein levels in the aged mice. Previous study found that ER␣ and ER␤ protein level significantly decreased in the hippocampal CA1 region of old vs. young rats and this decrease was correlated with a significant increase in ER␣ and ER␤ interaction with C terminus of heat shock cognate protein 70 (Hsc70)-interacting protein (CHIP) and robust ubiquitination of ER␣ and ER␤ [15] . These results suggest that the loss of E2 efficacy in the aged postmenopausal animals may resulted from the irreversible down-regulation of ER␣ and ER␤ protein expression.
Conclusion
In conclusion, we demonstrate that exogenous E2 treatment does not exert neuroprotective effects in aged female mice. Furthermore, we present evidence that this phenomenon may be related to the down-regulation of ER␣ and ER␤ protein in the cerebral cortex of aged female mice.
